Reducing ExacTrac intrafraction imaging uncertainty for prostate stereotactic body radiotherapy using a pre-treatment CBCT

被引:2
|
作者
Jordan, Barry [1 ]
Munoz, Luis [1 ]
Colyer, Christopher [1 ]
机构
[1] St Andrews Hosp Oncol, GenesisCare, Adelaide, SA, Australia
关键词
ExacTrac; CBCT; SBRT; Intrafraction; Prostate; IGRT; BEAM COMPUTED-TOMOGRAPHY; GUIDED RADIOTHERAPY; RADIATION-THERAPY; ORGAN MOTION; MULTIINSTITUTIONAL CONSORTIUM; GEOMETRIC ACCURACY; RADIOPAQUE MARKERS; IMPLANTED MARKERS; FIDUCIAL MARKERS; CANCER;
D O I
10.1007/s13246-022-01121-7
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
This study evaluated the intrafractional auto-matching uncertainties of prostate-implanted fiducial markers when using the ExacTrac v6.5 (Brainlab, Feldkirchen, Germany) X-ray stereoscopic system. A customised phantom with 3 implanted gold seeds was initially positioned at the isocentre using a cone beam CT (CBCT) prior to intrafractional imaging. Progressive offsets were applied to the phantom in all six directions (3 translational, 3 rotational) of 0 mm, 1 mm, 2 mm, 0 degrees, 1 degrees and 2 degrees. Subsequently, the ability of the ExacTrac image-matching functions to detect and correct these offsets was tested. For comparison, this procedure was repeated, but without a CBCT for pre-treatment positioning. The auto-matching uncertainties when a CBCT was introduced into the workflow were significantly reduced, and overall, the auto-matching statistics using the implanted marker (seeds) matching function was found to be more precise than the bony anatomy function in-phantom. The total standard deviations for the translational shifts using the implanted marker and bony anatomy functions respectively were 0.1 mm and 0.3 mm vertically, 0.1 mm and 0.3 mm longitudinally, and 0.1 mm and 0.4 mm laterally. The standard deviations for the rotational shifts using the implanted marker and bony anatomy matching functions respectively were 0.2 degrees and 1.2 degrees for the yaw (angle vert), 0.3 degrees and 1.1 degrees for the pitch (angle long), and 0.2 degrees and 1.2 degrees for the roll (angle lat) directions. The reduced uncertainties from introducing a CBCT for initial localisation resulted in decreased probability of inhibits due to false positives during treatment.
引用
收藏
页码:547 / 558
页数:12
相关论文
共 50 条
  • [21] Stereotactic Body Radiotherapy: An Emerging Treatment Approach for Localized Prostate Cancer
    Freeman, D. E.
    Friedland, J.
    Masterson-McGary, M.
    Spellberg, D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S307 - S308
  • [22] Stereotactic Body Radiotherapy: An Emerging Treatment Approach for Localized Prostate Cancer
    Friedland, Jay L.
    Freeman, Debra E.
    Masterson-McGary, Mary Ellen
    Spellberg, David M.
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2009, 8 (05) : 387 - 392
  • [23] Clinical Implementation and Utility of Triggered kV Imaging During Spine Stereotactic Body Radiotherapy for Intrafraction Motion Management
    Koo, J.
    Nardella, L.
    Degnan, M.
    Andreozzi, J.
    Yu, H. H. M.
    Penagaricano, J. A.
    Johnstone, P. A. S.
    Oliver, D. E.
    Ahmed, K. A.
    Rosenburg, S.
    Wuthrick, E. J.
    Diaz, R.
    Feygelman, V.
    Moros, E. G.
    Redler, G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E554 - E555
  • [24] Stereotactic body radiotherapy for prostate cancer: treatment approaches and clinical outcomes
    Miralbell, Raymond
    JOURNAL OF RADIOSURGERY AND SBRT, 2011, 1 (02): : 147 - 154
  • [25] CYBERKNIFE STEREOTACTIC BODY RADIOTHERAPY AS THE TREATMENT OF PROSTATE CANCER: PRELIMINARY REPORT
    Lee, Y. H.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S358 - S358
  • [26] Stereotactic body radiotherapy in the treatment of oligometastatic prostate cancer: early results
    Reeves, F.
    Bowden, P.
    Costello, A.
    BJU INTERNATIONAL, 2014, 113 : 130 - 131
  • [27] Impact of Immobilization on Intrafraction Motion for Spine Stereotactic Body Radiotherapy Using Cone Beam Computed Tomography
    Li, Winnie
    Sahgal, Arjun
    Foote, Matthew
    Millar, Barbara-Ann
    Jaffray, David A.
    Letourneau, Daniel
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (02): : 520 - 526
  • [28] Imaging Biomarkers in Prostate Stereotactic Body Radiotherapy: A Review and Clinical Trial Protocol
    Liu, Wei
    Loblaw, Andrew
    Laidley, David
    Fakir, Hatim
    Mendez, Lucas
    Davidson, Melanie
    Kassam, Zahra
    Lee, Ting-Yim
    Ward, Aaron
    Thiessen, Jonathan
    Bayani, Jane
    Conyngham, John
    Bailey, Laura
    Andrews, Joseph D.
    Bauman, Glenn
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [29] PREDICTION OF INTRAFRACTION PROSTATE MOTION: ACCURACY OF PRE- AND POST-TREATMENT IMAGING AND INTERMITTENT IMAGING
    Noel, Camille
    Parikh, Parag J.
    Roy, Meghana
    Kupelian, Patrick
    Mahadevan, Arul
    Weinstein, Geoffrey
    Enke, Charles
    Flores, Nicholas
    Beyer, David
    Levine, Lisa
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 73 (03): : 692 - 698
  • [30] Stereotactic body radiotherapy for oligo-metastatic liver disease - Influence of pre-treatment chemotherapy and histology on local tumor control
    Klement, R. J.
    Guckenberger, M.
    Alheid, H.
    Allgaeuer, M.
    Becker, G.
    Blanck, O.
    Boda-Heggemann, J.
    Brunner, T.
    Duma, M.
    Gerum, S.
    Habermehl, D.
    Hildebrandt, G.
    Lewitzki, V.
    Ostheimer, C.
    Papachristofilou, A.
    Petersen, C.
    Schneider, T.
    Semrau, R.
    Wachter, S.
    Andratschke, N.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 (02) : 227 - 233